H Lundbeck A/S HLBBF:OTCPK

RT Quote | Exchange | USD
Last | 07/18/22 EDT
5.00UNCH (UNCH)
52 week range
4.73 - 5.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.00
  • 52 Week High5.00
  • 52 Week High Date07/18/22
  • 52 Week Low4.73
  • 52 Week Low Date07/13/22

Key Stats

  • Market Cap912.81M
  • Shares Out198.65M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.00
  • 52 Week High5.00
  • 52 Week High Date07/18/22
  • 52 Week Low4.73
  • 52 Week Low Date07/13/22
  • Market Cap912.81M
  • Shares Out198.65M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On H Lundbeck A/S

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s...
Lene Skole-Soerensen
Deputy Chairman of the Board
Lars Rasmussen
Independent Chairman of the Board
Deborah Dunsire M.D.
President, Chief Executive Officer
Anders Goetzsche
Chief Financial Officer, Executive Vice President
Jacob Tolstrup
Executive Vice President - Commercial Operations, Chief Commercial Officer
Address
Ottiliavej 9
Valby
2500
Denmark